Yarwood, G D <br/><br/>
Administration of human recombinant insulin-like growth factor-I in critically ill patients.  [electronic resource] 

 -  Critical care medicine  Aug 1997 
 - 1352-61 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0090-3493 
<br/><br/><label>Standard No.: </label>10.1097/00003246-199708000-00023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Critical Illness<br/>Female<br/>Growth Hormone--blood<br/>Humans<br/>Insulin-Like Growth Factor Binding Protein 1--blood<br/>Insulin-Like Growth Factor Binding Protein 3--blood<br/>Insulin-Like Growth Factor I--pharmacokinetics<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Recombinant Proteins--pharmacokinetics<br/>Survival Analysis<br/>Systemic Inflammatory Response Syndrome--drug therapy